Page last updated: 2024-09-04

sk&f 83959 and Dyskinesia, Drug-Induced

sk&f 83959 has been researched along with Dyskinesia, Drug-Induced in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Croke, DT; Fienberg, AA; Grandy, DK; Kinsella, A; Koshikawa, N; Makihara, Y; Nally, RE; O'Sullivan, G; Sibley, DR; Tighe, O; Tomiyama, K; Waddington, JL; Yamamoto, H1
Chen, J; Ma, L; Wang, F; Zhang, H; Zhen, X1
Gerlach, J; Peacock, L1

Other Studies

3 other study(ies) available for sk&f 83959 and Dyskinesia, Drug-Induced

ArticleYear
Disruption of orofacial movement topographies in congenic mutants with dopamine D5 but not D4 receptor or DARPP-32 transduction 'knockout'.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2006, Volume: 16, Issue:6

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Chromans; Dopamine and cAMP-Regulated Phosphoprotein 32; Dyskinesia, Drug-Induced; Mice; Mice, Congenic; Mice, Inbred C57BL; Mice, Knockout; Receptors, Dopamine D4; Receptors, Dopamine D5; Signal Transduction

2006
Chronic SKF83959 induced less severe dyskinesia and attenuated L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease.
    Neuropharmacology, 2007, Volume: 53, Issue:1

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Drug Administration Schedule; Drug Interactions; Dyskinesia, Drug-Induced; Levodopa; Male; Movement; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Spiperone; Sympatholytics; Time Factors

2007
Aberrant behavioral effects of a dopamine D1 receptor antagonist and agonist in monkeys: evidence of uncharted dopamine D1 receptor actions.
    Biological psychiatry, 2001, Oct-01, Volume: 50, Issue:7

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Arousal; Behavior, Animal; Cebus; Cross-Over Studies; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dyskinesia, Drug-Induced; Dystonia; Locomotion; Receptors, Dopamine D1; Stereotyped Behavior

2001